Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-29 @ 8:04 PM
Study NCT ID:
NCT02521792
Status:
TERMINATED
Last Update Posted:
2020-10-19
First Post:
2015-08-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
Sponsor:
Clementia Pharmaceuticals Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-06
First Submit QC Date:
None
Study First Post Date:
2015-08-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-07-17
Results First Submit QC Date:
None
Results First Post Date:
2020-10-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-23
Last Update Post Date:
2020-10-19
Last Update Post Date Type:
ACTUAL